COMP <GO>
MDT vs AXGN // OPERATING MARGIN
Medtronic plc. (NYSE) VS. Axogen Inc. (NASDAQ) • 15-METRIC TALLY: MDT 7
— AXGN 5
▲ OPERATING MARGIN LEADER: MDT
LAST: $97.11 (+2.46%) • MKT CAP: $124.22B
operating-margins
17.80%
LAST: $49.63 (+0.77%) • MKT CAP: $2.96B
operating-margins
-3.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MDT VS. AXGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MDT | AXGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 65.00% | 74.30% | -9.30 | AXGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | -2.60% | +10.40 | MDT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.4x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.37% | -0.10% | +4.47 | MDT | /fcf-yield <GO> |
| Operating Margin ACTIVE | 17.80% | -3.50% | +21.30 | MDT | /operating-margins <GO> |
| Net Profit Margin | 0.00% | -7.00% | +7.00 | MDT | /net-margins <GO> |
| Revenue Growth (YoY) | 8.40% | 20.20% | -11.80 | AXGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.93% | 0.00% | +2.93 | MDT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.08 | 18.64 | -15.56 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | MDT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.8 | 74.3 | -12.50 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.10 | -0.19 | AXGN | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $124.22B | $2.96B | $121.25B | MDT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MDT REV | AXGN REV | MDT GROSS % | AXGN GROSS % | MDT FCF | AXGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $36.36B | $225.2M | 65.0% | 74.3% | $5.43B | -$2.9M |
| FY 2024 | $33.54B | $187.3M | 65.3% | 75.8% | $5.18B | $1.4M |
| FY 2023 | $32.36B | $159.0M | — | — | $5.33B | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MDT // BETA 0.91
AXGN // BETA 1.10